Symptoms requiring immediate medical attention include severe abdominal pain that does not resolve, persistent vomiting, or signs of allergic reaction
On April 17, Eli Lilly announced that its drug orforglipron became the first oral GLP-1 to successfully complete a Phase 3 trial for safety and efficacy for people with diabetes and obesity
Oral drops and sublingual formulations interact directly with the upper GI lining, which can cause more upper GI symptoms (nausea) but sometimes less lower GI disruption (constipation)
These medications represent a significant advancement in care by helping to regulate blood sugar, reduce appetite, and support healthy weight loss
The gut microbiome in children is still developing, and introducing Akkermansia muciniphila during this developmental window could have unpredictable effects on microbial succession and immune system training
Social media is full of before-and-after stories, transformation photos, and testimonials about how these treatments are reshaping lives
